Investment thesis · explained
What an investment thesis actually is.
A thesis is a claim about a stock that can be proven wrong, and a good one says up front exactly what would prove it. That one line is the difference between research you can check and a story you can only believe.
What an investment thesis is
A thesis has four parts. The claim: what you expect the stock to do, and why. The pillars: the few things that have to hold for the claim to be right. The catalysts: the dated events that will test it. And the test that would prove it wrong. Analysts call that test an invalidation trigger; on FrontierPicks it is the kill line.
Most of what passes for a thesis is only the first part: a confident claim, with the reasoning left out and nothing that could show it was wrong. That reads well and tells you nothing. A claim you can act on names the pillars it rests on, so you know what to watch, and the dated events that will test them.
Why a thesis has to be falsifiable
A claim is falsifiable when a specific condition would prove it wrong. If every outcome can be read as confirmation, the claim is too vague to use, because it can never be checked against what happens.
Once a thesis has a kill line, the outcome is no longer a matter of opinion: the line was crossed or it was not. The portfolio works the same way: every stock it buys comes with a written case and up to three business facts that would end it, set down before the purchase, and is measured against the S&P 500 on the track record.
A kill line is not a stop-loss
The two are easy to mix up. A stop-loss protects money: it is the price at which you sell a stock you own to limit a loss, whatever the reason for the fall.
A kill line tests an argument: a price or a business fact, published in advance, that would prove the research wrong, whether or not anyone owns the stock. You can be stopped out of a thesis that was right, and you can hold one whose kill line has already been crossed. They answer different questions.
On FrontierPicks the kill line belongs to the research note, not to the portfolio. Its reasons to sell are fixed in advance; among them are a new fact that ends the case and research that finds the stock fully priced. The portfolio has no stop-loss, and a note's kill line is not one: a sharp move prompts fresh research on the case. Every reason to sell.
How to evaluate a thesis
Four questions separate a thesis you can check from one you can only agree or disagree with. They work on anyone's research, ours included.
Is the claim specific?
A thesis that says what has to be true, and why, can be tested. One that only tells a story cannot.
See a research note taken apart →Is there a kill line?
The test, written down before the outcome, that would prove the claim wrong: a price, a business fact, or both. Without one, nothing can show the claim was wrong.
Why trust it →Are both sides argued?
A bull case and a bear case, written with the same care. A one-sided pitch hides the evidence against it.
Browse the stocks →Is it dated?
When was the claim made, and what did the earlier version say? An undated thesis can be rewritten after the fact.
Read the dated journal →Across the research notes
1,125 FrontierPicks research notes carry a kill line, set before the outcome is known. Three of the most recently updated, with the kill line as published:
- SOUN SoundHound AI, Inc
Kill line: A daily close above $4.26, the 5 November 2026 close before the third-quarter report, which would show the shares had recovered the whole post-report decline; or a raised 2027 revenue outlook above…
- CHA Chagee Holdings Limited
Kill line: A daily close below $10.30, under the $12.33 close of 11 November 2026 even after the $1.95 dividend leaves the price around the 23 November 2026 record date, which would show the dividend rally…
- QCOM QUALCOMM Incorporated
Kill line: A weekly close above $180, over the $179.60 close of 26 October 2026 and the 50-day moving average, which would show the shares leading again; or Qualcomm raising its $5 billion fiscal 2027…
A FrontierPicks research note is built on this idea: one claim that can be proven wrong, with its kill line published. The research notes on all 1,125 stocks include both a dated thesis and a kill line, the stated test that would prove the note wrong. To see how Claude writes one from news, company releases and filings, read what AI equity research is, then see a live one taken apart part by part.
Common questions
- What is an investment thesis?
- An investment thesis is a claim about a stock that can be proven wrong: what has to be true, why, and the test, a price or a business fact, that would show it was wrong. A good one states that test in advance, so the claim can be checked later.
- What is an invalidation trigger?
- It is the condition, stated in advance, that would prove a thesis wrong. On FrontierPicks it is called the kill line. It is published with the research note, before the outcome is known, so there is nothing to explain away later.
- How is a kill line different from a stop-loss?
- A stop-loss protects money: it is the price at which you sell a stock you own to limit a loss. A kill line tests an argument: a price or a business fact that would prove the research wrong, whether or not anyone owns the stock. On FrontierPicks the kill line belongs to the research note, and the portfolio does not sell on it. Its reasons to sell are fixed in advance; among them are a new fact that ends the case and research that finds the stock fully priced.
- How do you critique an investment thesis?
- Ask four questions. Is the claim specific enough to test? Does it have a kill line stated in advance? Are the bull and bear cases argued with the same care? And is it dated, so it cannot be rewritten after the outcome? A thesis that fails any of these cannot be checked.
- What makes a thesis falsifiable?
- A thesis is falsifiable when a stated condition would prove it wrong. If every outcome can be read as confirmation, nothing can test it, and it cannot be graded. Falsifiability is what lets a claim be checked against what happens.